BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1350723)

  • 1. Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results?
    Brinkerhoff CJ; Traynor JR; Linderman JJ
    J Theor Biol; 2008 Dec; 255(3):278-86. PubMed ID: 18761019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-limited reactions in G-protein activation: unexpected consequences of antagonist and agonist competition.
    Brinkerhoff CJ; Choi JS; Linderman JJ
    J Theor Biol; 2008 Apr; 251(4):561-9. PubMed ID: 18289560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unique encounter with paraprotenemia.
    Pallavi B; Krishnamurthy U
    J Lab Physicians; 2019; 11(4):391-393. PubMed ID: 31929711
    [No Abstract]   [Full Text] [Related]  

  • 4. Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.
    Levitt ES; Purington LC; Traynor JR
    Mol Pharmacol; 2011 Mar; 79(3):461-71. PubMed ID: 21098043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both ligand- and cell-specific parameters control ligand agonism in a kinetic model of g protein-coupled receptor signaling.
    Kinzer-Ursem TL; Linderman JJ
    PLoS Comput Biol; 2007 Jan; 3(1):e6. PubMed ID: 17222056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling ligand induced activation and desensitization of G-protein-coupled receptors.
    Woolf PJ; Linderman JJ
    Biophys J; 2003 Jan; 84(1):3-13. PubMed ID: 12524261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists.
    Neilan CL; Akil H; Woods JH; Traynor JR
    Br J Pharmacol; 1999 Oct; 128(3):556-62. PubMed ID: 10516632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric equilibrium model explains steady-state coupling of beta-adrenergic receptors to adenylate cyclase in turkey erythrocyte membranes.
    Ugur O; Onaran HO
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):765-76. PubMed ID: 9169611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Monte Carlo study of the dynamics of G-protein activation.
    Mahama PA; Linderman JJ
    Biophys J; 1994 Sep; 67(3):1345-57. PubMed ID: 7811949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo simulations of membrane signal transduction events: effect of receptor blockers on G-protein activation.
    Mahama PA; Linderman JJ
    Ann Biomed Eng; 1995; 23(3):299-307. PubMed ID: 7631983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the kinetic constants for binding of epinephrine to beta-adrenergic receptors of the S49 cell.
    Stickle D; Barber R
    Biochem Pharmacol; 1991 Aug; 42(5):1069-77. PubMed ID: 1651730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic receptors and their mode of coupling to adenylate cyclase.
    Levitzki A
    Physiol Rev; 1986 Jul; 66(3):819-54. PubMed ID: 3016770
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of coupling of the beta-adrenergic receptor to adenylate cyclase--an overview.
    Minocherhomjee AM; Roufogalis BD
    Gen Pharmacol; 1982; 13(2):87-93. PubMed ID: 6284585
    [No Abstract]   [Full Text] [Related]  

  • 14. The encounter coupling model for beta-adrenergic receptor/GTP-binding protein interaction in the S49 cell. Calculation of the encounter frequency.
    Stickle D; Barber R
    Biochem Pharmacol; 1992 May; 43(9):2015-28. PubMed ID: 1350723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
    Stickle D; Barber R
    Mol Pharmacol; 1993 Mar; 43(3):397-411. PubMed ID: 8095693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.